Rights and permissions
About this article
Cite this article
SSRIs, TCAs and lofepramine: no difference in cost effectiveness. Pharmacoecon. Outcomes News 505, 8 (2006). https://doi.org/10.2165/00151234-200605050-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605050-00028